GameStop Corp. (ETR:GS2C)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 11, 2025	Feb 1, 2025	Feb 3, 2024	Jan 28, 2023	Jan 29, 2022	Jan 30, 2021
Market Capitalization	8,787	11,563	4,167	6,396	6,662	17,442
Market Cap Growth	131.57%	177.53%	-34.86%	-3.99%	-61.80%	7538.87%
Enterprise Value	4,826	7,568	3,615	5,966	5,995	18,026
Last Close Price	19.32	26.64	13.30	18.03	20.98	69.25
PE Ratio	47.81	91.54	671.06	-	-	-
PS Ratio	2.71	3.14	0.85	1.17	1.24	4.16
PB Ratio	2.00	2.44	3.36	5.25	4.64	48.48
P/TBV Ratio	2.00	2.44	3.36	5.25	4.64	48.48
P/FCF Ratio	22.96	92.74	-	132.76	-	332.38
P/OCF Ratio	22.24	82.49	-	64.17	-	171.16
EV/Sales Ratio	1.53	2.06	0.74	1.09	1.11	4.30
EV/EBITDA Ratio	13.98	365.87	159.22	-	-	-
EV/EBIT Ratio	97.30	-	-	-	-	-
EV/FCF Ratio	12.61	60.70	-	123.83	-	343.52
Debt / Equity Ratio	0.35	0.08	0.45	0.47	0.41	2.40
Debt / EBITDA Ratio	4.37	1.19	1.65	15.11	11.35	4.97
Debt / FCF Ratio	4.06	3.17	-	11.79	-	16.43
Asset Turnover	0.73	0.89	1.81	1.79	2.01	1.92
Inventory Turnover	4.65	4.87	6.05	5.70	6.15	5.24
Quick Ratio	7.59	7.27	1.38	1.15	1.04	0.46
Current Ratio	8.39	8.05	2.11	1.74	1.92	1.16
Return on Equity (ROE)	6.62%	4.19%	0.50%	-21.41%	-37.40%	-40.95%
Return on Assets (ROA)	0.72%	-0.25%	-0.68%	-6.87%	-7.96%	-6.16%
Return on Capital (ROIC)	0.84%	-0.30%	-1.02%	-10.84%	-12.73%	-9.93%
Return on Capital Employed (ROCE)	0.90%	-	-	-	-	-
Earnings Yield	2.09%	1.09%	0.15%	-4.51%	-5.13%	-1.02%
FCF Yield	4.36%	1.08%	-5.31%	0.75%	-6.67%	0.30%
Buyback Yield / Dilution	-44.93%	-29.37%	-0.30%	-4.75%	-11.69%	25.71%
Total Shareholder Return	-	-29.37%	-0.30%	-4.75%	-11.69%	25.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.